First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study
Titel:
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study
Auteur:
Hideo-Kajita, Alexandre Garcia-Garcia, Hector M. Haude, Michael Joner, Michael Koolen, Jacques Ince, Hüseyin Abizaid, Alexandre Toelg, Ralph Lemos, Pedro A. von Birgelen, Clemens Christiansen, Evald Høj Wijns, William Neumann, Franz-Josef Kaiser, Christoph Eeckhout, Eric Teik, Lim Soo Escaned, Javier Azizi, Viana Kuku, Kayode O. Ozaki, Yuichi Dan, Kazuhiro Waksman, Ron